News Features Year in Review: Low-Risk TAVR Trials Big in 2019, but QoL Data Impresses, Too Michael O'Riordan December 18, 2019
News Daily News Societies Propose Volume, Proficiency Needs for Mitral Interventions Todd Neale December 17, 2019
News Daily News Higher Chili Pepper Consumption Linked to Fewer CVD Deaths L.A. McKeown December 17, 2019
News Daily News Physicians as Patients: Better Health, Less CV Prevention Among Ontario Doctors Than General Public Yael L. Maxwell November 26, 2019
News Conference News AHA 2019 Dapagliflozin Has Benefits Across Heart Failure Subgroups Todd Neale November 17, 2019
News Conference News AHA 2019 No Benefit of Colchicine in All-Comers PCI Shelley Wood November 17, 2019
News Conference News AHA 2019 ISCHEMIA Countdown Begins, but a ‘Black-and-White’ Answer Is Uncertain Shelley Wood October 25, 2019
News Daily News Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery Todd Neale October 23, 2019
News Daily News Risk Prediction Model Personalizes Revascularization Options for FREEDOM-Like Patients Michael O'Riordan October 17, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
Presentation TCT 2019 PARTNER 3: Health Status Outcomes From a Randomized Trial of Transcatheter vs. Surgical Aortic Valve Replacement in Patients With Severe Aortic Stenosis at Low Surgical Risk Presenter: Suzanne Baron September 29, 2019
News Conference News TCT 2019 No Safety Signal Seen for CTO PCI at 3 Years: EUROCTO Yael L. Maxwell September 29, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Four: Costs and Quality of Life Take Center Stage Shelley Wood September 29, 2019
News Analysis Hints at Survival Benefit With Revascularization in Stable Patients With Myocardial Ischemia Michael O'Riordan September 24, 2019
News Conference News HFSA 2019 DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF L.A. McKeown September 16, 2019
News Conference News ESC 2019 BMI Not the Best Option for Predicting CV Events, Global Analysis Suggests Yael L. Maxwell September 02, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News PolyIran: Polypill Prevents Major Cardiovascular Events Over 5 Years Todd Neale August 23, 2019
News Daily News Thwarted Access to PCSK9 Inhibitors Linked to Greater Risk of Major CV Events Marcus A. Banks July 25, 2019
News Daily News DCB Match DES Through 1 Year in Femoropopliteal Lesions, DRASTICO Affirms Caitlin E. Cox July 11, 2019